NAME OF DOSAGE/FREQUENCY/ INDICATION CONTRAINDICAT SIDE EFFECTS / NURSING

MEDICATION ROUTE ION ADVERSE INTERVENTION

REACTION
• OXYTOCIN • 10 units of oxytocic • Induction or • Significant • Cardiac • Ensure fetal
hormone/mL via IV stimulation of cephalopelvic arrhythmias, position, size, and
(Pitocin) infusion labor; disproportion; Hypertension, absence of
Subarachnoid complications that
• Control of • Unfavourable fetal hemorrhage are contraindicated
postpartum positions or with oxytocin
bleeding; presentation; • Fetal bradycardia; before therapy.
Neonatal jaundice;
• Obstetric • Regulate rate of
• As adjunctive Low APGAR score
emergencies that oxytocin delivery to
therapy in the
favour surgical • Nausea; Vomiting establish uterine
management of
intervention; contractions that
incomplete or
• Anaphylactic are similar to labor,
inevitable abortion.
• Prolonged use in reaction fetal monitoring is
severe toxemia; preferred.

• Uterine inertia • Monitor the BP

during oxytocin
• Hypertonic uterine administration;
patters discontinue drug
and notify physician
• Induction or with any sign of
augmentation of hypertensive
labor when vaginal emergency.
birth is
contraindicated

• Previous Cesarean
Section delivery.

NAME OF DOSAGE/FREQUENCY/ INDICATION CONTRAINDICAT SIDE EFFECTS / NURSING

 MEDICATION ROUTE
• METHYLERGONO IM:
VINE MALEATE
• 0.2 mg after delivery of
(Methergine) placenta, after delivery of
the anterior shoulder, or
during puerperium.
• May be repeated every 2-
4 hr
IV:
• Same dosage as IM;
infuse slowly over at
least 60 sec.
• Monitor BP very carefully
as severe hypertensive
reaction may occur,
reverse this route for
emergency situations.
ORAL:
• 0.2 mg PO tid or qid daily
in the puerperium for up
to 1 wk.
ION ADVERSE INTERVENTION
REACTION
• Routine • Contraindicated • Dizziness, • Administer by IM
management after with allergy to headache, tinnitus, injection or orally
delivery of the methylergonovine, diaphoresis. unless emergency
placenta. hypertension, requires IV use.
toxemia, lactation, • Hypertension, Complications are
• Treatment of pregnancy. palpitations, chest more frequent with
postpartum atony pain, dyspnea. IV use.
and hemorrhage; • Use cautiously with
subinvolution of sepsis, obliterate • Nausea, vomiting. • Monitor postpartum
the uterus. vascular disease, women for BP
hepatic or renal changes, amount,
• Uterine stimulation impairment. and character of
during the second vaginal bleeding.
stage of labor
following the • Discontinue if signs
delivery of the of toxicity occurs.
anterior shoulder,
under strict • Avoid prolonged
medical use of the drug.
supervision.
 NAME OF DOSAGE/FREQUENCY/ INDICATION CONTRAINDICAT SIDE EFFECTS / NURSING

MEDICATION ROUTE ION ADVERSE INTERVENTION

REACTION

• PHYTOMENADIO • 0.1 cc via IM to the • To stimulate the • Contraindicated to • The synthetic form • Ensure that the
NE Vastus Lateralis of the clotting factors of those who are of Vitamin K and adequate dose is
newborn. the newborn. hypersensitive to Vitamin K3 given while
(Vitamin K, any component of (Menadione) can following the proper
Phylloquinone, • To prevent Vitamin K cause allergic IM Drug
menaquinone) hemorrhagic containing reaction, Hemolytic Administration.
disease of the products Anemia, and
newborn. Cytotoxicity in liver • Apply pressure to
cells. the injection site to
prevent further
bleeding.

• Document the
giving of the
medication to
newborn to prevent
an accidental
doubling of the
dose.
• OXYTETRACYCLI • 1 cm strip applied from • To prevent • None • Irritation • None
NE HCL the inner canthus of the infection of the eye
eye to the outer canthus which may derive • Redness
(Terramycin from flora or
Opthalmic present infections • Tearing
Ointment, Terak, of the vagina
Terramycin with during normal • Iching sensation
Polymyxin B) spontaneous
delivery

• To prevent
Opthalmia
neonatorum in
infants.